Palantir Earnings: Investors Brace for Volatility as Focus Shifts to Guidance

Palantir Technologies (NYSE: PLTR) is scheduled to release its second-quarter financial results after market close, in a highly anticipated report that could determine the stock's direction for the remainder of the year. While Wall Street expects another strong quarter, the focus for investors has shifted beyond a simple earnings beat to the company's full-year guidance, which will be critical in justifying its premium valuation.

High Expectations Amid Market Scrutiny

Analysts have set a high bar for the data analytics firm, with consensus estimates pointing to revenue of $1.81 billion, an 81% increase year-over-year, and earnings per share (EPS) of $0.34. Despite a history of surpassing expectations—beating EPS estimates for seven consecutive quarters—Palantir's stock has fallen 30.6% year-to-date from its peak.

The stock's performance reflects investor unease with its valuation, which includes a trailing price-to-earnings ratio exceeding 130x. This lofty multiple leaves little room for disappointment, as evidenced by the stock's negative reaction to its last two earnings reports, despite beating estimates. The options market is currently pricing in a potential post-earnings move of ±9.6%.

The Bull Case: Commercial Acceleration and Government Strength

Optimism for Palantir centers on two key areas: accelerating commercial growth and sustained government contracts. Bulls point to the company's U.S. commercial revenue, which grew 121% year-over-year in the first quarter. According to Oppenheimer, this growth may have accelerated to over 135% in Q2, driven by the adoption of its Artificial Intelligence Platform (AIP).

Key points supporting the bull thesis include:

Ad

• Strong Government Pipeline: Analysts at Oppenheimer project government revenue growth of over 85%, bolstered by defense spending and a new partnership with Mercury Systems to automate U.S. military factory operations.
• Guidance as a Catalyst: Many believe the true catalyst for the stock will be an upward revision to its full-year 2026 guidance, which currently stands at $7.18 billion to $7.20 billion. Analysts at Citi and D.A. Davidson have recently issued positive notes, citing the growth trajectory and improving profitability.

The Bear Case: Valuation Risks and Competitive Headwinds

Conversely, bears argue that Palantir's valuation remains unsustainable, even after the recent pullback. Jefferies maintains an Underperform rating with a $70 price target, citing the need for flawless execution to justify a forward revenue multiple between 50x and 90x.

Concerns for investors include:

• Competitive Pressure: Cleveland Research noted that data from Palantir's commercial partners in Q2 was only in line with or below plans, suggesting increased competition.
• Insider Selling: Recent share sales by executives, including $24.05 million by CTO Sankar Shyam, have drawn attention, though they were conducted under pre-arranged 10b5-1 trading plans.
• International Challenges: The company faces regulatory hurdles in the United Kingdom, including a blocked police contract and scrutiny over a major National Health Service (NHS) deal, potentially capping its global expansion narrative.